Search - tctmd.com

Displaying 321 - 340 of 1293

Sort: Relevancy | Date

News Conference News ESC 2020

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

L.A. McKeown

September 03, 2020

News Industry News

Enrolment initiated in World’s First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

August 28, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

PAD Patients Undertreated With Statins Despite Elevated CV Risk

L.A. McKeown

July 13, 2020

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

News Daily News

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

L.A. McKeown

July 02, 2020

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

L.A. McKeown

June 29, 2020

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA II BTK Clinical Trial in VIVA Late-Breaking Session

June 26, 2020

News Conference News HRS 2020

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Michael O'Riordan

May 21, 2020

News Daily News

Recovered Paclitaxel PAD Data Shift the Mortality Picture

L.A. McKeown

May 14, 2020

News Daily News

German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs

L.A. McKeown

May 11, 2020

News Daily News

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

Shelley Wood

May 06, 2020

News Daily News

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Yael L. Maxwell

April 28, 2020

News Daily News

Patient PCI Radiation Dose Highly Variable Across Hospitals

L.A. McKeown

April 14, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

Presentation ACC 2020

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Presenter: William Hiatt

March 29, 2020

News Conference News ACC 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

L.A. McKeown

March 28, 2020

News Conference News ACC 2020

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

Todd Neale

March 28, 2020

News Daily News

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

Todd Neale

March 27, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

Advertisement

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

Enrolment initiated in World’s First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

PAD Patients Undertreated With Statins Despite Elevated CV Risk

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

Intact Vascular Announces Positive One-Year Data from TOBA II BTK Clinical Trial in VIVA Late-Breaking Session

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Recovered Paclitaxel PAD Data Shift the Mortality Picture

German COVID-19 Autopsy Data Show Thromboembolism, ‘Heavy’ Lungs

Kawasaki Link to COVID-19 in Kids Probed as UK, New York Issue Alerts

Different Markers of Dyslipidemia Could Help Fine-tune CVD Prevention

Patient PCI Radiation Dose Highly Variable Across Hospitals

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

Diabetes May Boost Benefits of COMPASS Dual Antithrombotic Approach

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content